G. F. Kahl

1.2k total citations
47 papers, 1.1k citations indexed

About

G. F. Kahl is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, G. F. Kahl has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Pharmacology and 10 papers in Oncology. Recurrent topics in G. F. Kahl's work include Pharmacogenetics and Drug Metabolism (16 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). G. F. Kahl is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). G. F. Kahl collaborates with scholars based in Germany, Cameroon and United States. G. F. Kahl's co-authors include Thomas M. Guenthner, Regine Kahl, D W Nebert, Howard J. Eisen, Allan B. Okey, Michelle E. Mason, Greg Bondy, Heidi Foth, K.J. Netter and Karen Ildico Hirsch‐Ernst and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Lipid Research.

In The Last Decade

G. F. Kahl

47 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. F. Kahl Germany 16 418 343 282 261 219 47 1.1k
J. Van Cantfort Belgium 15 352 0.8× 270 0.8× 138 0.5× 179 0.7× 204 0.9× 33 864
Maro Christou United States 16 531 1.3× 372 1.1× 302 1.1× 329 1.3× 234 1.1× 25 1.0k
John W. Cameron United States 3 532 1.3× 251 0.7× 183 0.6× 183 0.7× 220 1.0× 3 863
J.A. Beamand United Kingdom 20 532 1.3× 566 1.7× 241 0.9× 263 1.0× 225 1.0× 34 1.4k
Craig B. Marcus United States 22 416 1.0× 542 1.6× 225 0.8× 221 0.8× 205 0.9× 51 1.4k
D. V. Parke United Kingdom 23 489 1.2× 435 1.3× 191 0.7× 284 1.1× 141 0.6× 50 1.5k
Gregory L. Kedderis United States 21 440 1.1× 358 1.0× 292 1.0× 440 1.7× 157 0.7× 43 1.4k
Guengerich Fp United States 13 558 1.3× 436 1.3× 147 0.5× 335 1.3× 207 0.9× 24 1.1k
Patricia Linko United States 18 587 1.4× 355 1.0× 325 1.2× 303 1.2× 229 1.0× 26 1.1k
Wattenberg Lw United States 9 331 0.8× 529 1.5× 104 0.4× 263 1.0× 143 0.7× 10 1.1k

Countries citing papers authored by G. F. Kahl

Since Specialization
Citations

This map shows the geographic impact of G. F. Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. F. Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. F. Kahl more than expected).

Fields of papers citing papers by G. F. Kahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. F. Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. F. Kahl. The network helps show where G. F. Kahl may publish in the future.

Co-authorship network of co-authors of G. F. Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of G. F. Kahl. A scholar is included among the top collaborators of G. F. Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. F. Kahl. G. F. Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirsch‐Ernst, Karen Ildico, et al.. (2001). Repression of Phenobarbital-Dependent CYP2B1 mRNA Induction by Reactive Oxygen Species in Primary Rat Hepatocyte Cultures. Molecular Pharmacology. 59(6). 1402–1409. 11 indexed citations
2.
Hirsch‐Ernst, Karen Ildico, et al.. (1998). Molecular cDNA Cloning and Tissue Distribution of mRNA Encoding a Novel ATP-Binding Cassette (ABC) Half-Transporter. Biochemical and Biophysical Research Communications. 249(1). 151–155. 15 indexed citations
3.
Hirsch‐Ernst, Karen Ildico, Christina Ziemann, C. Schmitz-Salue, Heidi Foth, & G. F. Kahl. (1995). Modulation of P-Glycoprotein and mdr1b mRNA Expression by Growth Factors in Primary Rat Hepatocyte Culture. Biochemical and Biophysical Research Communications. 215(1). 179–185. 49 indexed citations
4.
Aubrecht, Jiri, G. F. Kahl, & Martin Höhne. (1993). Regulation of Fibronectin mRNA Expression in Primary Hepatocytes in Response to EGF and Phenobarbital. Biochemical and Biophysical Research Communications. 190(3). 1023–1028. 7 indexed citations
5.
Foth, Heidi, et al.. (1992). Increased cotinine elimination and cotinine-N-oxide formation by phenobarbital induction in rat and mouse. Journal of Molecular Medicine. 70-70(3-4). 175–81. 5 indexed citations
6.
Foth, Heidi, et al.. (1990). Pulmonary elimination and metabolism of 5-fluoro-2'-deoxyuridine in isolated perfused rat lung and lung slices.. Drug Metabolism and Disposition. 18(6). 1011–1017. 8 indexed citations
7.
Foth, Heidi, U. Walther, & G. F. Kahl. (1990). Increased hepatic nicotine elimination after phenobarbital induction in the conscious rat. Toxicology and Applied Pharmacology. 105(3). 382–392. 8 indexed citations
8.
Foth, Heidi, Regine Kahl, & G. F. Kahl. (1988). Pharmacokinetics of low doses of benzo[a]pyrene in the rat. Food and Chemical Toxicology. 26(1). 45–51. 58 indexed citations
9.
Foth, Heidi, et al.. (1987). Eightfold induction of nicotine elimination in perfused rat liver by pretreatment with phenobarbital. Biochemical and Biophysical Research Communications. 148(1). 192–198. 14 indexed citations
10.
Kahl, Regine, et al.. (1980). Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.. PubMed. 8(4). 191–6. 45 indexed citations
11.
Guenthner, Thomas M., G. F. Kahl, & Daniel W. Nebert. (1980). NADPH-cytochrome P-450 reductase: Preferential inhibition by ellipticine and other type II compounds having little effect on NADPH-cytochrome c reductase. Biochemical Pharmacology. 29(1). 89–95. 25 indexed citations
12.
Kahl, G. F., et al.. (1979). Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices. Biochemical Pharmacology. 28(7). 1051–1056. 26 indexed citations
13.
Kahl, G. F., et al.. (1978). Differential inhibition of biphenyl hydroxylation in perfused rat liver. Naunyn-Schmiedeberg s Archives of Pharmacology. 304(3). 297–301. 7 indexed citations
14.
Kugler, Michaël, et al.. (1978). Enhancement of Nitro Reduction in Rat Liver Microsomes by Haemin and Haemoproteins. Xenobiotica. 8(5). 281–288. 5 indexed citations
15.
Kahl, Regine, et al.. (1978). Binding of benzo(a)pyrene metabolites to cellular DNA in perfused rat lungs. Naunyn-Schmiedeberg s Archives of Pharmacology. 303(3). 303–307. 13 indexed citations
16.
Kahl, G. F., Regine Kahl, Kenji Kumaki, & D W Nebert. (1976). Association of the Ah locus with specific changes in metyrapone and ethylisocyanide binding to mouse liver microsomes.. Journal of Biological Chemistry. 251(17). 5397–5407. 15 indexed citations
17.
Kahl, G. F., et al.. (1971). Action of metyrapone on the redox state of free nicotinamide-adenine dinucleotide and on oxygen consumption of perfused rat livers and isolated mitochondria. Naunyn-Schmiedeberg s Archives of Pharmacology. 268(1). 1–16. 2 indexed citations
18.
Kahl, G. F., et al.. (1970). Metabolism of metyrapone by a soluble enzyme system in rat liver. Naunyn-Schmiedeberg s Archives of Pharmacology. 267(3). 293–296. 3 indexed citations
19.
Kahl, G. F.. (1970). Experiments on the metyrapone reducing microsomal enzyme system. Naunyn-Schmiedeberg s Archives of Pharmacology. 266(1). 61–74. 24 indexed citations
20.
Kahl, G. F. & K.J. Netter. (1970). The effect of metyrapone on cellular respiration and microsomal drug oxidation. Biochemical Pharmacology. 19(1). 27–34. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Van Cantfort Breakdown of academic impact, for papers by Maro Christou Breakdown of academic impact, for papers by John W. Cameron Breakdown of academic impact, for papers by J.A. Beamand Breakdown of academic impact, for papers by Craig B. Marcus Breakdown of academic impact, for papers by D. V. Parke Breakdown of academic impact, for papers by Gregory L. Kedderis Breakdown of academic impact, for papers by Guengerich Fp Breakdown of academic impact, for papers by Patricia Linko Breakdown of academic impact, for papers by Wattenberg Lw
Rankless by CCL
2026